Yuhan Corporation supplies HIV APIs worth of KRW 48.2 billion to Gilead

Published: 2018-01-05 16:10:20

Updated: 2018-01-05 16:10:20

Yuhan Corporation officially announced conclusion of the supply agreement active pharmaceutical ingredients for the treatment of HIV(HIV API) with ‘Gilead Sciences Ireland UC’ on the 3^rd.

Its upfront payment was about KRW 48.218 billion; the APIs will be supplied to Ireland.

The agreement will be valid from 3 January 2018 to 31 March 2019.

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.